Search

HarvardScience is a publication of the Harvard Office of News and Public Affairs devoted to all matters related to science at the various schools, departments, institutes, and hospitals of Harvard University.
Harvard Science medicine + health
In mouse models of fatal encephalitis caused by two different related viruses, Priti Kumar (right), Manjunath Swamy, and Premlata Shankar (not pictured) showed that a single short interfering RNA worked as a broad-spectrum antiviral agent.

(Graham Ramsay)

RNA sequence restrains fatal encephalitis

March 10, 2006

One short sequence of RNA protected mice from deadly brain inflammation caused by West Nile virus and Japanese encephalitis virus, report Priti Kumar, Manjunath Swamy, and Premlata Shankar. The findings, which appear online and in the April 2006 PLoS Medicine, underscore the therapeutic potential of the fast-moving field of RNA interference. It has only been four years since scientists first showed that RNA interference, which protects plants, flies, and worms from viral infections, also works in mammalian cells. Now, at least two experimental siRNA therapies already have advanced to phase I safety trials in people. Short interfering RNA (siRNA) silences genes most commonly by triggering the destruction of RNA before proteins can be made.

foundations environments animal, vegetable, + mineral medicine + health culture + society engineering + technology